BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 8392596)

  • 21. The bovine papillomavirus type 1 E5 transforming protein specifically binds and activates the beta-type receptor for the platelet-derived growth factor but not other related tyrosine kinase-containing receptors to induce cellular transformation.
    Goldstein DJ; Li W; Wang LM; Heidaran MA; Aaronson S; Shinn R; Schlegel R; Pierce JH
    J Virol; 1994 Jul; 68(7):4432-41. PubMed ID: 8207816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative role of the human papillomavirus type 16 E5 gene during the productive stage of the viral life cycle.
    Genther SM; Sterling S; Duensing S; Münger K; Sattler C; Lambert PF
    J Virol; 2003 Mar; 77(5):2832-42. PubMed ID: 12584306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The human papillomavirus HPV2a E5 protein localizes to the Golgi apparatus and modulates signal transduction.
    Cartin W; Alonso A
    Virology; 2003 Sep; 314(2):572-9. PubMed ID: 14554085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of human papillomavirus type 16 oncogenes on MAP kinase activity.
    Gu Z; Matlashewski G
    J Virol; 1995 Dec; 69(12):8051-6. PubMed ID: 7494320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human papillomaviruses target the double-stranded RNA protein kinase pathway.
    Hebner CM; Wilson R; Rader J; Bidder M; Laimins LA
    J Gen Virol; 2006 Nov; 87(Pt 11):3183-3193. PubMed ID: 17030851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification.
    Suprynowicz FA; Krawczyk E; Hebert JD; Sudarshan SR; Simic V; Kamonjoh CM; Schlegel R
    J Virol; 2010 Oct; 84(20):10619-29. PubMed ID: 20686024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The E5 protein of HPV-6, but not HPV-16, associates efficiently with cellular growth factor receptors.
    Conrad M; Goldstein D; Andresson T; Schlegel R
    Virology; 1994 May; 200(2):796-800. PubMed ID: 7909971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The human papillomavirus type 16 E5 gene cooperates with the E7 gene to stimulate proliferation of primary cells and increases viral gene expression.
    Bouvard V; Matlashewski G; Gu ZM; Storey A; Banks L
    Virology; 1994 Aug; 203(1):73-80. PubMed ID: 8030286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papillomavirus 16 immortalization of normal human ectocervical epithelial cells alters retinoic acid regulation of cell growth and epidermal growth factor receptor expression.
    Sizemore N; Rorke EA
    Cancer Res; 1993 Oct; 53(19):4511-7. PubMed ID: 8402622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Casein kinase II activities related to hyperphosphorylation of human papillomavirus type 16-E7 oncoprotein in epidermal keratinocytes.
    Hashida T; Yasumoto S
    Biochem Biophys Res Commun; 1990 Oct; 172(2):958-64. PubMed ID: 2173586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidermal growth factor receptor-dependent stimulation of differentiation by human papillomavirus type 16 E5.
    Trammel J; Amusan O; Hultgren A; Raikhy G; Bodily JM
    Virology; 2024 Feb; 590():109952. PubMed ID: 38103269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the influences of the E5 transforming protein on kinetic parameters of epidermal growth factor binding and metabolism.
    Waters CM; Overholser KA; Sorkin A; Carpenter G
    J Cell Physiol; 1992 Aug; 152(2):253-63. PubMed ID: 1639860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The HPV-16 E5 protein represses expression of stress pathway genes XBP-1 and COX-2 in genital keratinocytes.
    Sudarshan SR; Schlegel R; Liu X
    Biochem Biophys Res Commun; 2010 Sep; 399(4):617-22. PubMed ID: 20688044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The human papillomavirus type 16 E5 oncoprotein synergizes with EGF-receptor signaling to enhance cell cycle progression and the down-regulation of p27(Kip1).
    Pedroza-Saavedra A; Lam EW; Esquivel-Guadarrama F; Gutierrez-Xicotencatl L
    Virology; 2010 Apr; 400(1):44-52. PubMed ID: 20144468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidermal growth factor (EGF) elicits down-regulation of human papillomavirus type 16 (HPV-16) E6/E7 mRNA at the transcriptional level in an EGF-stimulated human keratinocyte cell line: functional role of EGF-responsive silencer in the HPV-16 long control region.
    Yasumoto S; Taniguchi A; Sohma K
    J Virol; 1991 Apr; 65(4):2000-9. PubMed ID: 1848315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A promoter within the E6 ORF of human papillomavirus type 16 contributes to the expression of the E7 oncoprotein from a monocistronic mRNA.
    Glahder JA; Hansen CN; Vinther J; Madsen BS; Norrild B
    J Gen Virol; 2003 Dec; 84(Pt 12):3429-3441. PubMed ID: 14645924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Connexin 43 expression is downregulated in raft cultures of human keratinocytes expressing the human papillomavirus type 16 E5 protein.
    Tomakidi P; Cheng H; Kohl A; Komposch G; Alonso A
    Cell Tissue Res; 2000 Aug; 301(2):323-7. PubMed ID: 10955727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The human papillomavirus type 16 E5 protein impairs TRAIL- and FasL-mediated apoptosis in HaCaT cells by different mechanisms.
    Kabsch K; Alonso A
    J Virol; 2002 Dec; 76(23):12162-72. PubMed ID: 12414956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. E-cadherin transfection down-regulates the epidermal growth factor receptor and reverses the invasive phenotype of human papilloma virus-transfected keratinocytes.
    Wilding J; Vousden KH; Soutter WP; McCrea PD; Del Buono R; Pignatelli M
    Cancer Res; 1996 Nov; 56(22):5285-92. PubMed ID: 8912870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.